Stocks and Investing Stocks and Investing
Mon, August 14, 2023

Robert Burns Reiterated (YMAB) at Strong Buy and Held Target at $11 on, Aug 14th, 2023


Published on 2024-10-28 05:53:33 - WOPRAI, Robert Burns
  Print publication without navigation


Robert Burns of HC Wainwright & Co., Reiterated "Y-mAbs Therapeutics, Inc." (YMAB) at Strong Buy and Held Target at $11 on, Aug 14th, 2023.

Robert has made no other calls on YMAB in the last 4 months.



There are 3 other peers that have a rating on YMAB. Out of the 3 peers that are also analyzing YMAB, 1 agrees with Robert's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Alec Stranahan of "B of A Securities" Maintained at Hold with Increased Target to $12 on, Monday, May 15th, 2023


These are the ratings of the 2 analyists that currently disagree with Robert


  • William Plovanic of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $22 on, Tuesday, July 25th, 2023
  • David Nierengarten of "Wedbush" Upgraded from Hold to Buy and Increased Target to $13 on, Wednesday, May 10th, 2023
Contributing Sources